Literature DB >> 6133718

Characterization of cimetidine, ranitidine, and related structures' interaction with cytochrome P-450.

S Rendić, F Kajfez, H H Ruf.   

Abstract

Cimetidine (I) interacts with the hemin iron of cytochrome P-450 from rat liver microsomes, with its imidazole and cyano coordinating groups. Ranitidine (II) interacts through its nitronic acid oxygen and its amine nitrogen, as shown by optical difference and ESR-spectra. I, N-cyano-N'[2-[[[5-(dimethylamino)-methyl-2-furanyl]methyl] thio]-ethyl]-N"-methyl guanidine (IV), 4(5)-hydroxymethyl-5(4)-methyl imidazole (VII), 4(5)-methyl-5(4)-[(2-aminoethyl)-thiomethyl]-imidazole hydrochloride (IX), 2-[[[(5-dimethylamino)-methyl-2-furanyl]-methyl]-thio]ethene amine dihydrochloride (X) and imidazole (XI) inhibit 7-ethoxycoumarin dealkylation competitively. In I both imidazole and cyano groups contribute to the inhibitory activity, the latter group being more effective according to electron spin resonance. Mixed type inhibition was observed with II, desmethylranitidine (VIII) and N-[[2-(5-methylimidazol-4-yl)methylthio]-ethyl]-N'-methyl-2-nitro-1, 1-ethenediamine (III). These compounds inhibited the reaction to a small extent; ranitidine S-oxide (VI) did not interact at all with microsomes from phenobarbital-pretreated rats. Using microsomes from 3-methylcholanthrene-pretreated rats, the affinities of interaction and the amplitudes of optical difference spectra were higher with VIII than with its parent, compound II.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6133718

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  35 in total

1.  Lack of effect of omeprazole treatment on steady-state plasma levels of metoprolol.

Authors:  T Andersson; P Lundborg; C G Regårdh
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 2.  Haematological adverse effects of histamine H2-receptor antagonists.

Authors:  J P Aymard; B Aymard; P Netter; B Bannwarth; P Trechot; F Streiff
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Nov-Dec

Review 3.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

Review 4.  Pharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugs.

Authors:  R K Verbeeck
Journal:  Clin Pharmacokinet       Date:  1990-07       Impact factor: 6.447

5.  A dog model for acetaminophen-induced fulminant hepatic failure.

Authors:  A Francavilla; L Makowka; L Polimeno; M Barone; J Demetris; J Prelich; D H Van Thiel; T E Starzl
Journal:  Gastroenterology       Date:  1989-02       Impact factor: 22.682

6.  Attenuation of rifampicin-induced theophylline metabolism by diltiazem/rifampicin coadministration in healthy volunteers.

Authors:  G I Adebayo; A Akintonwa; A F Mabadeje
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

7.  Lack of efficacy of cimetidine and ranitidine as inhibitors of tolbutamide metabolism.

Authors:  G I Adebayo; H A Coker
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

8.  Lack of inhibitory effect of metronidazole on theophylline disposition in healthy subjects.

Authors:  G I Adebayo; A F Mabadeje
Journal:  Br J Clin Pharmacol       Date:  1987-07       Impact factor: 4.335

9.  Influence of cimetidine on steady state concentration and metabolite formation from antipyrine infused with a rectal osmotic mini pump.

Authors:  M W Teunissen; C H Kleinbloesem; L G de Leede; D D Breimer
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 10.  Pharmacokinetic drug interactions in anaesthetic practice.

Authors:  M Wood
Journal:  Clin Pharmacokinet       Date:  1991-10       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.